Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia

Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga

28-06-2023

https://doi.org/10.4081/btvb.2023.72

582

PDF: 194
Vaccine-induced immune thrombotic thrombocytopenia following ChAdOx1 nCoV-19 vaccine: report of two cases

Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò

23-05-2022

https://doi.org/10.4081/btvb.2022.23

3747

PDF: 268
Artificial intelligence and machine learning in hemostasis and thrombosis

Paolo Gresele

30-12-2023

https://doi.org/10.4081/btvb.2023.105

2433

PDF: 493
Thrombin generation assay in COVID-19 patients shows a hypocoagulable pattern

Giovanni L. Tiscia, Donatella Colaizzo, Antonio De Laurenzo, Filomena Cappucci, Lucia Fischetti, Elena Chinni, Mario Mastroianno, Giovanni Favuzzi, Massimo Carella, Elvira Grandone

22-10-2024

https://doi.org/10.4081/btvb.2024.145

1859

PDF: 270

Supplementary: 188
Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato

21-03-2023

https://doi.org/10.4081/btvb.2023.59

560

PDF: 227
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth

16-05-2024

https://doi.org/10.4081/btvb.2024.115

720

PDF: 224
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

27-06-2023

https://doi.org/10.4081/btvb.2023.84

1254

PDF: 287

Supplementary File: 155
Allopurinol-induced acquired von Willebrand syndrome

Juan Eirís, Marina Suárez-Terrón, Pablo Granados, David Martínez-Campuzano, Ana Rosa Cid, Saturnino Haya, Santiago Bonanad

25-10-2023

https://doi.org/10.4081/btvb.2023.88

1599

PDF: 191
Pathways for lower extremity superficial vein thrombosis management in an academic medical center

Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt

24-03-2025

https://doi.org/10.4081/btvb.2025.155

199

PDF: 43
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators

12-10-2023

https://doi.org/10.4081/btvb.2023.92

801

PDF: 225
A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients

Pantep Angchaisuksiri, Wolfram Ruf, Jeffrey Weitz, Sam Schulman, Guy A. Young

01-07-2025

https://doi.org/10.4081/btvb.2025.188

404

PDF: 123
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

Paolo Simioni, Vittorio Pengo, Paolo Prandoni

07-11-2022

https://doi.org/10.4081/btvb.2022.52

2019

PDF: 225
Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review

Rosina Albisinni, Tommaso Marrazzo, Arta Karruli, Sabrina Manduca, Giuseppe Nobile, Nicola Galdieri, Marisa De Feo

24-10-2022

https://doi.org/10.4081/btvb.2022.44

574

PDF: 186
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker

16-05-2024

https://doi.org/10.4081/btvb.2024.120

829

PDF: 328
Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia

Bianca Clerici, Mariangela Scavone, Gian Marco Podda

20-06-2024

https://doi.org/10.4081/btvb.2024.127

1912

PDF: 519
Stroke in women: anticoagulation in a complicated puzzle

Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona

26-08-2024

https://doi.org/10.4081/btvb.2024.137

1094

PDF: 292
The use of creatine and the development of deep vein thrombosis. A scoping review

Kartik Akkihal, Thomas Varkey, James Kelbert

18-11-2024

https://doi.org/10.4081/btvb.2024.142

3289

PDF: 274

Supplementary: 100
Distal deep vein thrombosis: is there a way out of this dark forest?

Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

04-09-2024

https://doi.org/10.4081/btvb.2024.129

734

PDF: 238
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

Mehrie H. Patel, Alok A. Khorana

16-05-2024

https://doi.org/10.4081/btvb.2024.113

538

PDF: 250
Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study

Mosaad Almegren

12-10-2023

https://doi.org/10.4081/btvb.2023.85

354

PDF: 155
From rare to aware: confronting Lemierre syndrome

Silvia Cardi, Filippo Catalani, Luca Valerio, Stefano Barco

21-10-2024

https://doi.org/10.4081/btvb.2024.147

1735

PDF: 358
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

https://doi.org/10.4081/btvb.2022.10

1062

PDF: 343

APPENDIX: 69
Is non-alcoholic fatty liver disease a prothrombotic risk factor?

Niccolò Bitto, Vincenzo La Mura, Anna Ludovica Fracanzani, Armando Tripodi

19-05-2023

https://doi.org/10.4081/btvb.2023.81

609

PDF: 193
Diagnosis and management of abnormal uterine bleeding in adolescence An expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)

Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele

08-05-2024

https://doi.org/10.4081/btvb.2024.106

885

PDF: 339
Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot

Rushad Patell, Jeffrey I. Zwicker, Rohan Singh, Simon Mantha

16-05-2024

https://doi.org/10.4081/btvb.2024.123

1378

PDF: 314
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

Ilaria Nichele, Giuseppe Carli, Alberto Tosetto

22-04-2024

https://doi.org/10.4081/btvb.2024.104

427

PDF: 142
Remembering the XXVI SISET Congress and the 50th anniversary of its foundation, 2020

Armando Tripodi

17-01-2025

https://doi.org/10.4081/btvb.2025.171

1048

PDF: 200
New perspectives for prevention of the post-thrombotic syndrome

Paolo Prandoni

22-03-2022

https://doi.org/10.4081/btvb.2022.20

1469

PDF: 447
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

16-05-2024

https://doi.org/10.4081/btvb.2024.118

813

PDF: 314
Welcome to the 12^th International Conference on Thrombosis and Hemostasis Issues in Cancer! Proceedings

Anna Falanga, Benjamin Brenner, Alok A. Khorana

16-05-2024

https://doi.org/10.4081/btvb.2024.138

1412

PDF: 260
The introduction of the international normalized ratio as a breakthrough event in the history of thrombosis

Armando Tripodi

23-01-2025

https://doi.org/10.4081/btvb.2025.169

667

PDF: 222
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

Ang Li, Emily Zhou

16-05-2024

https://doi.org/10.4081/btvb.2024.108

738

PDF: 285
Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?

Simon Noble

16-05-2024

https://doi.org/10.4081/btvb.2024.125

1194

PDF: 192
Artificial intelligence, platelets and aspirin

Giovanni de Gaetano

15-03-2024

https://doi.org/10.4081/btvb.2024.130

404

PDF: 186
Evaluation of Coaguchek<sup>®</sup>Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study

Cristina Legnani, Michela Cini, Sophie Testa, Alberto Tosetto, Claudia Dellanoce, Stefania Bellesso, Giuseppe Carli, Ilaria Nichele, Laura Lissandrini, Serena Zorzi, Emilia Antonucci, Gualtiero Palareti

01-12-2022

https://doi.org/10.4081/btvb.2022.37

1471

PDF: 298
At the age of three

Giovanni de Gaetano, Chiara Cerletti

16-12-2024

https://doi.org/10.4081/btvb.2024.166

283

PDF: 82
Well begun is half done

Giovanni de Gaetano

14-12-2022

https://doi.org/10.4081/btvb.2022.61

1538

PDF: 161
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

Marco P. Donadini, Walter Ageno

15-04-2022

https://doi.org/10.4081/btvb.2022.22

2030

PDF: 532
Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy

Tiziano Barbui

21-07-2022

https://doi.org/10.4081/btvb.2022.38

2905

PDF: 308
Antithrombotic therapy in idiopathic infertility

Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso

03-10-2024

https://doi.org/10.4081/btvb.2024.126

1956

PDF: 457
What is the gender of thrombosis? A natural model of precision medicine

Rossella Marcucci, Rosanna Abbate

03-08-2023

https://doi.org/10.4081/btvb.2023.87

502

PDF: 178
Welcome to AICE and sincere wishes for peace for the new year 2024

Giovanni de Gaetano

27-12-2023

https://doi.org/10.4081/btvb.2023.107

1258

PDF: 135
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

Agnes Y.Y. Lee

29-02-2024

https://doi.org/10.4081/btvb.2024.111

1484

PDF: 318
Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

27-07-2022

https://doi.org/10.4081/btvb.2022.34

4619

PDF: 394

Supplementary Files: 120
The balance between hemorrhage and thrombosis in patients surviving spontaneous intracerebral bleeding: the nightmare of a neurologist

Alessandro Pezzini

21-08-2024

https://doi.org/10.4081/btvb.2024.151

1295

PDF: 351
Hemostasis and the kidney: an unforeseen initial opportunity to create a small research group that grew into an institute

Carlamaria Zoja, Ariela Benigni, Giuseppe Remuzzi

30-06-2025

https://doi.org/10.4081/btvb.2025.190

0

PDF: 0

Supplementary: 0
Welcome to the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer! Oral Communications and Posters

Anna Falanga, Benjamin Brenner, Alok A. Khorana

16-05-2024

https://doi.org/10.4081/btvb.2024.139

426

PDF: 354
SISET50: trajectories of hemostasis and thrombosis in Italy 1970-2020

Giovanni de Gaetano, Maria Benedetta Donati, Americo Bonanni

17-01-2025

https://doi.org/10.4081/btvb.2025.170

990

PDF: 209
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles

Nadim Tawil, Lata Adnani, Janusz Rak

16-05-2024

https://doi.org/10.4081/btvb.2024.109

430

PDF: 169
The evolution of hemostasis genetics: from monogenic disorders to complex traits. A historical perspective

Augusto Di Castelnuovo

01-07-2025

https://doi.org/10.4081/btvb.2025.184

267

PDF: 96
How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

Anna Falanga, Hugo Ten Cate, Bianca Rocca

27-01-2023

https://doi.org/10.4081/btvb.2023.60

683

PDF: 304
Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship”

Marco Marietta, Giancarlo Castaman

01-07-2025

https://doi.org/10.4081/btvb.2025.180

987

PDF: 335
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele

23-05-2022

https://doi.org/10.4081/btvb.2022.19

4657

PDF: 267
Role of platelet autophagy in cardiovascular diseases

Luca D'Ambrosio, Maurizio Forte, Giacomo Frati, Sebastiano Sciarretta

26-08-2024

https://doi.org/10.4081/btvb.2024.133

871

PDF: 231
Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know

Giovanni Tiscia, Elvira Grandone

13-09-2022

https://doi.org/10.4081/btvb.2022.43

2195

PDF: 256
Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

Sarah Gallitto, Thomas C. Varkey, Jacob Lahti

13-12-2024

https://doi.org/10.4081/btvb.2024.131

1182

PDF: 201
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

03-08-2023

https://doi.org/10.4081/btvb.2023.90

1390

PDF: 461
Author's Reply. Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

05-12-2024

https://doi.org/10.4081/btvb.2024.163

556

PDF: 117
Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial"

Vittorio Pengo

01-07-2025

https://doi.org/10.4081/btvb.2025.179

368

PDF: 97
28^th SISET National Congress | Rome, Italy, 6-9 November 2024

Società Italiana per lo Studio dell'Emostasi e Trombosi – SISET

06-11-2024

https://doi.org/10.4081/btvb.2024.160

1969

PDF: 413
An ecological alliance against air pollution and cardiovascular disease

Pier Mannuccio Mannucci

22-03-2022

https://doi.org/10.4081/btvb.2022.21

1746

PDF: 285
Growing weapons to fight hemophilia

Pier Mannuccio Mannucci

23-02-2023

https://doi.org/10.4081/btvb.2023.64

771

PDF: 312
Venous thromboembolism and mortality in patients with hematological malignancies

Kristen M. Sanfilippo, Tzu-Fei Wang

16-05-2024

https://doi.org/10.4081/btvb.2024.119

698

PDF: 252
A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system"

Sergio Coccheri

24-10-2022

https://doi.org/10.4081/btvb.2022.48

1681

PDF: 274
The 2024 Nobel prize in Medicine: impact on hemostasis and thrombosis research

Loredana Bury, Marco Malvestiti, Paolo Gresele

19-11-2024

https://doi.org/10.4081/btvb.2024.159

944

PDF: 223
The clinical usefulness of measuring thrombin generation

Coenraad H. Hemker

06-03-2023

https://doi.org/10.4081/btvb.2023.62

835

PDF: 365
Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators

23-05-2022

https://doi.org/10.4081/btvb.2022.28

5225

PDF: 453

APPENDIX: 122
Thrombotic thrombocytopenic purpura: much done, but still a lot to do

Paola Binetti

29-08-2024

https://doi.org/10.4081/btvb.2024.149

517

PDF: 179
Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond

Cristina Santoro, Alessandro Casini

03-08-2023

https://doi.org/10.4081/btvb.2023.75

1135

PDF: 280
Polycythemia vera and management of the thrombotic risk: an update

Massimo Franchini

20-12-2023

https://doi.org/10.4081/btvb.2023.102

1882

PDF: 282
The von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis

Stefano Lancellotti, Monica Sacco, Maira Tardugno, Antonietta Ferretti, Raimondo De Cristofaro

26-04-2022

https://doi.org/10.4081/btvb.2022.11

2026

PDF: 351
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

04-09-2024

https://doi.org/10.4081/btvb.2024.144

905

PDF: 206

SUPPLEMENTARY MATERIAL: 93
Endothelial cell dysfunction in cancer: a not-so-innocent bystander

Betül Ünlü, Neha Joshi, Jamie M. O'Sullivan

16-05-2024

https://doi.org/10.4081/btvb.2024.116

1294

PDF: 248
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia

17-10-2022

https://doi.org/10.4081/btvb.2022.40

2393

PDF: 228
The importance of rigorous and engaging scientific communication

Giovanni de Gaetano

01-07-2025

https://doi.org/10.4081/btvb.2025.191

399

PDF: 152
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

Gary E. Raskob

16-05-2024

https://doi.org/10.4081/btvb.2024.124

566

PDF: 230
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

09-03-2023

https://doi.org/10.4081/btvb.2023.53

694

PDF: 353
Gene transfer in hemophilia A: not cogent yet

Pier Mannuccio Mannucci

20-04-2022

https://doi.org/10.4081/btvb.2022.32

2036

PDF: 234
The new era of anticoagulation: factor XI and XII inhibitors

Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

07-06-2023

https://doi.org/10.4081/btvb.2023.76

2179

PDF: 864
Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

16-05-2024

https://doi.org/10.4081/btvb.2024.114

510

PDF: 190

1 - 80 of 80 items

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy